A better understanding of transmission dynamics is essential in influenza pandemic planning. If a substantial proportion of transmissions were to occur during the presymptomatic phase or from asymptomatic individuals, then infection control measures such as contact tracing and quarantine of exposures would be of limited value. Infectiousness has been inferred based on the presence of influenza in the upper respiratory tract rather than from transmission experiments. Although asymptomatic individuals may shed influenza virus, studies have not determined if such people effectively transmit influenza.
We performed a systematic review of published studies describing the relationship between viral shedding and disease transmission. Based on the available literature, we found that there is scant, if any, evidence that asymptomatic or presymptomatic individuals play an important role in influenza transmission. As such, recent articles concerning pandemic planning, some using transmission modeling, may have overestimated the effect of presymptomatic or asymptomatic influenza transmission. More definitive transmission studies are sorely needed.
References
1.
DayTParkAMadrasNGumelAWuJ.When is quarantine a useful control strategy for emerging infectious diseases?Am J Epidemiol2006;163:479–85.
2.
FraserCRileySAndersonRMFergusonNM. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci USA2004;101:6146–51.
3.
HalloranMEFergusonNMEubankSLonginiIMJrCummingsDALewisB, Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci USA2008;105:4639–44.
4.
CarratFVerguEFergusonNMLamaitreMCauchemezSLeachS, Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am J Epidemiol2008;167:775–85.
5.
GermannTCKadauKLonginiIMJrMackenCA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci USA2006;103:5935–40.
6.
LonginiIMJrNizamAXuSUngchusakKHanshaoworakulWCummingsDA, Containing pandemic influenza at the source. Science2005;309:1083–7.
7.
GlassRJGlassLMBeyelerWEMinHJ. Targeted social distancing design for pandemic influenza. Emerg Infect Dis2006;12:1671–81.
8.
WuJTRileySFraserCLeungGM. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med2006;3:e361.
9.
ElvebackLRFoxJPAckermanELangworthyABoydMGatewoodL.An influenza simulation model for immunization studies. Am J Epidemiol1976;103:152–65.
10.
BellDM;World Health Organization Writing Group. Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis2006;12:88–94.
11.
EcclesR.Asymptomatic spread of flu is not proved. BMJ2005;331: 1145.
12.
LowenACMubarekaSSteelJPaleseP.Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog2007;3:1470–6.
13.
SchulmanJLKilbourneED. Experimental transmission of influenza virus infection in mice. I. The period of transmissibility. J Exp Med1963;118:257–66.
14.
SchulmanJLKilbourneED. Experimental transmission of influenza virus infection in mice. II. Some factors affecting the incidence of transmitted infection. J Exp Med1963;118:267–75.
15.
LowenACMubarekaSTumpeyTMGarcia-SastreAPaleseP.The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci USA2006;103:9988–92.
16.
HerlocherMLEliasSTrusconRHarrisonSMindellDSimonC, Ferrets as a transmission model for influenza: Sequence changes in HA1 of type A (H3N2) virus. J Infect Dis2001;184:542–6.
17.
CouchRBDouglasRGJrFedsonDSKaselJA. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis1971;124:473–80.
18.
BjornsonABMellencampMASchiffGM. Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis1991;143(5 Pt 1):1062–6.
19.
MurphyBRChalhubEGNusinoffSRKaselJChanockRM. Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man. J Infect Dis1973;128:479–87.
20.
HallCBDolinRGalaCLMarkovitzDMZhangYQMadorePH, Children with influenza A infection: Treatment with rimantadine. Pediatrics1987;80:275–82.
21.
FrankALTaberLHWellsCRWellsJMGlezenWPParedesA.Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis1981;144:433–41.
22.
MontoASKoopmanJSLonginiIMJr., Tecumseh study of illness. XIII. Influenza infection and disease, 1976–1981. Am J Epidemiol1985;12:811–22.
23.
PhilipRNBellJADavisDJBeemMOBeigelmanPMEnglerJI, Epidemiologic studies on influenza in familial and general population groups, 1951–1956. II. Characteristics of occurrence. Am J Hyg1961;73:123–37.
24.
DavisDJPhilipRNBellJAVogelJEJensenDV. Epidemiologic studies on influenza in familial and general population groups. 1951–1956. III. Laboratory observations. Am J Hyg1961;73:138–47.
25.
FoyHMCooneyMKAllanIDAlbrechtJK. Influenza B in households: Virus shedding without symptoms or antibody response. Am J Epidemiol1987;126:506–15.
26.
SheatK.An investigation into an explosive outbreak of influenza—New Plymouth. Communicable Disease New Zealand1992;92:18–9.
27.
BridgesCBKuehnertMJHallCB. Transmission of influenza: Implications for control in health care settings. Clin Infect Dis2003;37:1094–101.
28.
HallCB. The spread of influenza and other respiratory viruses: Complexities and conjectures. Clin Infect Dis2007;45:353–9.
29.
PapineniRSRosenthalFS. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med1997;10:105–16.
